Literature DB >> 19153192

Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues.

Dimo Dietrich1, Ralf Lesche, Reimo Tetzner, Manuel Krispin, Jörn Dietrich, Wolfgang Haedicke, Matthias Schuster, Glen Kristiansen.   

Abstract

A procedure for simultaneous quantification of DNA methylation of several genes in minute amounts of sample material was developed and applied to microdissected formalin-fixed and paraffin-embedded breast tissues. The procedure is comprised of an optimized bisulfite treatment protocol suitable for samples containing only few cells, a multiplex preamplification and subsequent locus specific reamplification, and a novel quantitative bisulfite sequencing method based on the incorporation of a normalization domain into the PCR product. A real-time PCR assay amplifying repetitive elements was established to quantify low amounts of bisulfite-treated DNA. Ten prognostic and diagnostic epigenetic breast cancer biomarkers (PITX2, RASSF1A, PLAU, LHX3, PITX3, LIMK1, SLITRK1, SLIT2, HS3ST2, and TFF1) were analyzed in tissue samples obtained from two patients with invasive ductal carcinoma of the breast. The microdissected samples were obtained from several areas within the tumor tissue, including intraductal and invasive carcinoma, adenosis, and normal ductal epithelia of adjacent normal tissue, as well as stroma, tumor infiltrating lymphocytes, and adipose tissue. Overall, reliable quantification was possible for all genes. For most genes, increased DNA methylation in invasive and intraductal carcinoma cells compared with other tissue components was observed. For TFF1, decreased methylation levels were observed in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153192      PMCID: PMC2674771          DOI: 10.1369/jhc.2009.953026

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  54 in total

1.  Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification.

Authors:  J Guillermo Paez; Ming Lin; Rameen Beroukhim; Jeffrey C Lee; Xiaojun Zhao; Daniel J Richter; Stacey Gabriel; Paula Herman; Hidefumi Sasaki; David Altshuler; Cheng Li; Matthew Meyerson; William R Sellers
Journal:  Nucleic Acids Res       Date:  2004-05-18       Impact factor: 16.971

2.  Degradation of DNA by bisulfite treatment.

Authors:  Kazuo Tanaka; Akimitsu Okamoto
Journal:  Bioorg Med Chem Lett       Date:  2007-01-24       Impact factor: 2.823

Review 3.  Tumor microenvironment: the role of the tumor stroma in cancer.

Authors:  Hanchen Li; Xueli Fan; Jeanmarie Houghton
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

4.  Identification of a unique epigenetic sub-microenvironment in prostate cancer.

Authors:  J Rodriguez-Canales; J C Hanson; M A Tangrea; H S Erickson; P S Albert; B S Wallis; A M Richardson; P A Pinto; W M Linehan; J W Gillespie; M J Merino; S K Libutti; K G Woodson; M R Emmert-Buck; R F Chuaqui
Journal:  J Pathol       Date:  2007-03       Impact factor: 7.996

Review 5.  Complementary techniques: laser capture microdissection--increasing specificity of gene expression profiling of cancer specimens.

Authors:  Giovanni Esposito
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

6.  Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.

Authors:  Pouya Pakneshan; Bernard Têtu; Shafaat A Rabbani
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

Review 7.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

8.  Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.

Authors:  Alex Soltermann; Verena Tischler; Stefanie Arbogast; Julia Braun; Nicole Probst-Hensch; Walter Weder; Holger Moch; Glen Kristiansen
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

9.  Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation.

Authors:  Edurne Arriola; Maryou B K Lambros; Chris Jones; Tim Dexter; Alan Mackay; David S P Tan; Narinder Tamber; Kerry Fenwick; Alan Ashworth; Mitch Dowsett; Jorge S Reis-Filho
Journal:  Lab Invest       Date:  2007-01       Impact factor: 5.662

10.  RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdissected prostatic epithelial tissues.

Authors:  Alan Aitchison; Anne Warren; David Neal; Pamela Rabbitts
Journal:  Prostate       Date:  2007-05-01       Impact factor: 4.104

View more
  36 in total

1.  Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis.

Authors:  Wei-Jie Zhou; Zhen H Geng; Shan Chi; Wenli Zhang; Xiao-Feng Niu; Shu-Jue Lan; Li Ma; Xuesong Yang; Li-Jing Wang; Yan-Qing Ding; Jian-Guo Geng
Journal:  Cell Res       Date:  2011-02-01       Impact factor: 25.617

Review 2.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 3.  Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?

Authors:  Tamas A Gonda; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Semin Cell Dev Biol       Date:  2009-10-17       Impact factor: 7.727

4.  Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.

Authors:  Barbara Kinga Barták; Alexandra Kalmár; Bálint Péterfia; Árpád V Patai; Orsolya Galamb; Gábor Valcz; Sándor Spisák; Barnabás Wichmann; Zsófia Brigitta Nagy; Kinga Tóth; Zsolt Tulassay; Péter Igaz; Béla Molnár
Journal:  Epigenetics       Date:  2017-09-26       Impact factor: 4.528

5.  The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.

Authors:  Zhaocai He; Xin Wang; Changhao Huang; Yu Gao; Chen Yang; Pengwei Zeng; Zihua Chen
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

6.  The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.

Authors:  Luka de Vos; Ingela Grünwald; Emma Grace Bawden; Jörn Dietrich; Kathrin Scheckenbach; Constanze Wiek; Romina Zarbl; Friedrich Bootz; Jennifer Landsberg; Dimo Dietrich
Journal:  Epigenetics       Date:  2020-04-21       Impact factor: 4.528

7.  CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.

Authors:  Dimo Dietrich; Manuel Krispin; Jörn Dietrich; Anne Fassbender; Jörn Lewin; Nadia Harbeck; Manfred Schmitt; Serenella Eppenberger-Castori; Vincent Vuaroqueaux; Frédérique Spyratos; John A Foekens; Ralf Lesche; John W M Martens
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

8.  A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene.

Authors:  Amandine Chatagnon; Esteban Ballestar; Manel Esteller; Robert Dante
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

9.  Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling.

Authors:  Nashi Widodo; Didik Priyandoko; Navjot Shah; Renu Wadhwa; Sunil C Kaul
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  Prediction of epigenetically regulated genes in breast cancer cell lines.

Authors:  Leandro A Loss; Anguraj Sadanandam; Steffen Durinck; Shivani Nautiyal; Diane Flaucher; Victoria E H Carlton; Martin Moorhead; Yontao Lu; Joe W Gray; Malek Faham; Paul Spellman; Bahram Parvin
Journal:  BMC Bioinformatics       Date:  2010-06-04       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.